Wolverine Trading
IONS icon

Wolverine Trading’s Ionis Pharmaceuticals IONS Stock Holding History

Wolverine Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.77M Buy
+27,585
New +$1.35M ﹤0.01% 2297
2025
Q1 		– Sell
-8,847
Closed -$290K – 5247
2024
Q4 		$309K Sell
8,847
-2,764
-24% -$103K ﹤0.01% 3976
2024
Q3 		$474K Sell
11,611
-9,717
-46% -$452K ﹤0.01% 3111
2024
Q2 		$1.02M Buy
21,328
+9,281
+77% +$381K ﹤0.01% 2178
2024
Q1 		$522K Buy
12,047
+2,552
+27% +$122K ﹤0.01% 2802
2023
Q4 		$480K Buy
+9,495
New +$455K ﹤0.01% 2995
2022
Q1 		– Sell
-108,529
Closed -$3.55M – 5882
2021
Q4 		$3.31M Buy
108,529
+1,651
+2% +$52K ﹤0.01% 1441
2021
Q3 		$3.59M Sell
106,878
-4,070
-4% -$153K ﹤0.01% 1569
2021
Q2 		$4.39M Buy
110,948
+1,337
+1% +$52.4K 0.01% 1265
2021
Q1 		$4.9M Buy
109,611
+92,142
+527% +$5.14M 0.01% 1126
2020
Q4 		$999K Sell
17,469
-183,120
-91% -$9.13M ﹤0.01% 2381
2020
Q3 		$9.72M Buy
200,589
+100,324
+100% +$5.57M 0.02% 546
2020
Q2 		$5.96M Sell
100,265
-252
-0.3% -$14K 0.02% 718
2020
Q1 		$4.85M Buy
100,517
+26,768
+36% +$1.49M 0.01% 777
2019
Q4 		$4.45M Sell
73,749
-22,391
-23% -$1.33M 0.01% 1196
2019
Q3 		$5.68M Buy
96,140
+13,636
+17% +$889K 0.02% 799
2019
Q2 		$5.3M Sell
82,504
-3,457
-4% -$244K 0.02% 854
2019
Q1 		$6.98M Sell
85,961
-21,274
-20% -$1.37M 0.02% 684
2018
Q4 		$5.51M Buy
107,235
+9,917
+10% +$506K 0.02% 751
2018
Q3 		$5.02M Buy
97,318
+81,335
+509% +$3.82M 0.01% 960
2018
Q2 		$705K Hold
15,983
– – ﹤0.01% 2638
2018
Q1 		$705K Buy
15,983
+5,357
+50% +$272K ﹤0.01% 2638
2017
Q4 		$534K Sell
10,626
-21,482
-67% -$1.18M ﹤0.01% 2914
2017
Q3 		$1.63M Buy
32,108
+18,906
+143% +$990K 0.01% 1483
2017
Q2 		$684K Sell
13,202
-21,832
-62% -$1.02M ﹤0.01% 2122
2017
Q1 		$1.42M Buy
35,034
+16,182
+86% +$727K 0.01% 1436
2016
Q4 		$902K Sell
18,852
-12,427
-40% -$492K ﹤0.01% 2005
2016
Q3 		$1.11M Buy
31,279
+4,917
+19% +$154K 0.01% 1753
2016
Q2 		$610K Buy
+26,362
New +$850K ﹤0.01% 2037

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's IONS Position: Q3 2025 in Review

Wolverine Trading opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2025: 27,585 shares worth $1.77M. The stake represents ﹤0.01% of the portfolio and ranks #2297 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IONS as recently as Q4 2024.

Wolverine Trading first reported a position in IONS in Q2 2016 and has held it in 29 quarters since. The position peaked at $9.72M in Q3 2020. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Wolverine Trading held 27,585 shares of Ionis Pharmaceuticals worth $1.77M as of Q3 2025.
  • Ionis Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
  • Ionis Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2297 holding.
  • Wolverine Trading first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 29 quarters since.
  • Wolverine Trading's Ionis Pharmaceuticals position peaked at $9.72M in Q3 2020.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.